Your browser doesn't support javascript.
loading
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Dulai, Parambir S; Boland, Brigid S; Singh, Siddharth; Chaudrey, Khadija; Koliani-Pace, Jenna L; Kochhar, Gursimran; Parikh, Malav P; Shmidt, Eugenia; Hartke, Justin; Chilukuri, Prianka; Meserve, Joseph; Whitehead, Diana; Hirten, Robert; Winters, Adam C; Katta, Leah G; Peerani, Farhad; Narula, Neeraj; Sultan, Keith; Swaminath, Arun; Bohm, Matthew; Lukin, Dana; Hudesman, David; Chang, John T; Rivera-Nieves, Jesus; Jairath, Vipul; Zou, G Y; Feagan, Brian G; Shen, Bo; Siegel, Corey A; Loftus, Edward V; Kane, Sunanda; Sands, Bruce E; Colombel, Jean-Frederic; Sandborn, William J; Lasch, Karen; Cao, Charlie.
Afiliação
  • Dulai PS; University of California-San Diego, La Jolla, California. Electronic address: pdulai@ucsd.edu.
  • Boland BS; University of California-San Diego, La Jolla, California.
  • Singh S; University of California-San Diego, La Jolla, California.
  • Chaudrey K; Mayo Clinic, Rochester, Minnesota.
  • Koliani-Pace JL; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Kochhar G; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Parikh MP; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Shmidt E; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Hartke J; Indiana University, Indianapolis, Indiana.
  • Chilukuri P; Indiana University, Indianapolis, Indiana.
  • Meserve J; University of California-San Diego, La Jolla, California.
  • Whitehead D; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Hirten R; North Shore University Hospital, Manhasset, New York.
  • Winters AC; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Katta LG; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Peerani F; Icahn School of Medicine at Mount Sinai, New York, New York; University of Alberta, Edmonton, Alberta, Canada.
  • Narula N; Icahn School of Medicine at Mount Sinai, New York, New York; McMaster University Medical Centre, Hamilton, Ontario, Canada.
  • Sultan K; North Shore University Hospital, Manhasset, New York.
  • Swaminath A; Lenox Hill Hospital, New York, New York.
  • Bohm M; Indiana University, Indianapolis, Indiana.
  • Lukin D; Montefiore Medical Center, New York, New York.
  • Hudesman D; New York University (NYU), New York, New York.
  • Chang JT; University of California-San Diego, La Jolla, California.
  • Rivera-Nieves J; University of California-San Diego, La Jolla, California.
  • Jairath V; University of Western Ontario, London, Ontario, Canada.
  • Zou GY; University of Western Ontario, London, Ontario, Canada.
  • Feagan BG; University of Western Ontario, London, Ontario, Canada.
  • Shen B; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Siegel CA; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Loftus EV; Mayo Clinic, Rochester, Minnesota.
  • Kane S; Mayo Clinic, Rochester, Minnesota.
  • Sands BE; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Colombel JF; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Sandborn WJ; University of California-San Diego, La Jolla, California.
  • Lasch K; Takeda Pharmaceuticals USA Inc., Deerfield, Illinois.
  • Cao C; Takeda Pharmaceuticals USA Inc., Deerfield, Illinois.
Gastroenterology ; 155(3): 687-695.e10, 2018 09.
Article em En | MEDLINE | ID: mdl-29857091

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados / Quimioterapia de Indução Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados / Quimioterapia de Indução Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Ano de publicação: 2018 Tipo de documento: Article